A carregar...
Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease
Reports have shown that antitumor necrosis factor alpha (anti-TNF-α) agents including infliximab (IFX) can dramatically suppress the disease activity of refractory vasculo-Behçet disease (vasculo-BD). However, it is completely unknown whether we can discontinue anti-TNF-α agents under clinical remis...
Na minha lista:
| Publicado no: | Case Rep Rheumatol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4808526/ https://ncbi.nlm.nih.gov/pubmed/27034879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/1467583 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|